These comprehensive analyses firmly establish the significant association between NDUFAF6 expression in breast cancer and several crucial clinical pathological parameters, strongly suggesting NDUFAF6 as a potential molecular biomarker in breast cancer patient's diagnosis, prognosis, and treatment. This evidence concerns the gene NDUFAF6 and breast cancer.